IL33107A - Ergoline derivatives - Google Patents
Ergoline derivativesInfo
- Publication number
- IL33107A IL33107A IL33107A IL3310769A IL33107A IL 33107 A IL33107 A IL 33107A IL 33107 A IL33107 A IL 33107A IL 3310769 A IL3310769 A IL 3310769A IL 33107 A IL33107 A IL 33107A
- Authority
- IL
- Israel
- Prior art keywords
- halogen
- derivative
- acid chloride
- formula
- reacting
- Prior art date
Links
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical class O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 title claims description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000155 melt Substances 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002908 adrenolytic effect Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- XXJGBENTLXFVFI-UHFFFAOYSA-N 1-amino-methylene Chemical compound N[CH2] XXJGBENTLXFVFI-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- VWQWXZAWFPZJDA-CGVGKPPMSA-N hydrocortisone succinate Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COC(=O)CCC(O)=O)[C@@H]4[C@@H]3CCC2=C1 VWQWXZAWFPZJDA-CGVGKPPMSA-N 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2217668 | 1968-10-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL33107A0 IL33107A0 (en) | 1969-12-31 |
| IL33107A true IL33107A (en) | 1973-02-28 |
Family
ID=11192615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL33107A IL33107A (en) | 1968-10-07 | 1969-10-02 | Ergoline derivatives |
Country Status (13)
-
1969
- 1969-09-26 NL NL6914648A patent/NL6914648A/xx unknown
- 1969-10-02 GB GB1230515D patent/GB1230515A/en not_active Expired
- 1969-10-02 IL IL33107A patent/IL33107A/en unknown
- 1969-10-02 BR BR212978/69A patent/BR6912978D0/pt unknown
- 1969-10-02 IE IE1370/69A patent/IE33331B1/xx unknown
- 1969-10-03 DK DK528269AA patent/DK124544B/da unknown
- 1969-10-03 DE DE19691950032 patent/DE1950032A1/de active Pending
- 1969-10-03 AT AT933869A patent/AT290738B/de not_active IP Right Cessation
- 1969-10-03 BE BE739809D patent/BE739809A/xx unknown
- 1969-10-03 FR FR696933833A patent/FR2020031B1/fr not_active Expired
- 1969-10-06 ES ES372227A patent/ES372227A1/es not_active Expired
- 1969-10-06 CH CH1501369A patent/CH518939A/de not_active IP Right Cessation
- 1969-10-06 NO NO3976/69A patent/NO124775B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1230515A (enrdf_load_html_response) | 1971-05-05 |
| NO124775B (enrdf_load_html_response) | 1972-06-05 |
| BR6912978D0 (pt) | 1973-05-24 |
| CH518939A (de) | 1972-02-15 |
| FR2020031A1 (enrdf_load_html_response) | 1970-07-10 |
| AT290738B (de) | 1971-06-11 |
| DK124544B (da) | 1972-10-30 |
| DE1950032A1 (de) | 1970-04-09 |
| IE33331B1 (en) | 1974-05-29 |
| NL6914648A (enrdf_load_html_response) | 1970-04-09 |
| ES372227A1 (es) | 1971-09-16 |
| IL33107A0 (en) | 1969-12-31 |
| BE739809A (enrdf_load_html_response) | 1970-04-03 |
| FR2020031B1 (enrdf_load_html_response) | 1973-07-13 |
| IE33331L (en) | 1970-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0168432B1 (ko) | 아미노 알콜의 티에닐카복실레이트, 이의 4급 생성물, 이들 화합물의 제조방법 및 이들 화합물을 함유하는 약제 | |
| WO1990014347A1 (en) | Indole derivatives and medicine | |
| JPS6023102B2 (ja) | 新規エピニンエステル、その製法及び医薬組成物 | |
| JPH03501606A (ja) | 特定の３‐置換２‐アルキルベンゾフラン誘導体 | |
| US2656366A (en) | Water-soluble esters of cortisone and related compounds | |
| US3847924A (en) | Certain scopolammonium compounds | |
| EP0703915B1 (en) | Xamoneline tartrate | |
| EP0009608B1 (en) | N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them | |
| IL33107A (en) | Ergoline derivatives | |
| JP3830816B2 (ja) | アザビシクロ（２．２．２）オクタン−３−アミンクエン酸塩の結晶多形及びそれらの医薬組成物 | |
| Gilman et al. | Dibenzofuran. V. dimetalation | |
| JP2834506B2 (ja) | 新規チエニルオキシ‐アルキルアミン誘導体、その製法及びこの化合物を含有する医薬 | |
| IL33226A (en) | Omega-nor and omega-homo pgf2beta derivatives and process for their preparation | |
| JPS5850240B2 (ja) | アンドロスタン系の新規なジエン誘導体の製造法 | |
| US3923996A (en) | 3-Substituted-oxindoles in compositions and methods of treating obesity | |
| US3925396A (en) | {62 -Pyridyl-carbonamido-alkane-sulfonic acid salts | |
| US3865838A (en) | (5-Indolyloxy)-acetic acid compounds and therapeutic compositions | |
| US3708510A (en) | Amides of cholanic acid,cholenic acid,and choladienic acid | |
| GB1565022A (en) | Methylamine derivatives and provesses for preparing the same | |
| US3880863A (en) | 17-Aralkyl-6 beta-azido-4,5 alpha-epox-ymorphinan-3-01{hu s | |
| EP0515159B1 (en) | Ursane derivatives, their preparation and pharmaceutical formulations thereof | |
| US3317544A (en) | 3-tropinyl esters of substituted acrylic and thio acrylic acids | |
| FI66382B (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbar 17,17's-bisspartein | |
| JPH0699364B2 (ja) | ズルシート類、その製造方法および該化合物の製造方法 | |
| US2753340A (en) | Maleate salts of protoveratrine a and protoveratrine b |